Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells
- 29 June 2015
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 47 (3) , 971-980
Abstract
Neuroblastoma is the most common cancer in infants and the fourth most common cancer in children. Aggressive cell growth and chemoresistance are notorious obstacles in neuroblastoma therapy. Exposure to the anticancer drug ellipticine inhibits efficiently growth of neuroblastoma cells and induces apoptosis in these cells. However, ellipticine induced resistance in these cells. The upregulation of a vacuolar (V)-ATPase gene is one of the factors associated with resistance development. In accordance with this finding, we found that levels of V-ATPase protein expression are higher in the ellipticine-resistant UKF-NB-4ELLI line than in the parental ellipticine-sensitive UKF-NB-4 cell line. Treatment of ellipticine-sensitive UKF-NB-4 and ellipticine-resistant UKF-NB-4ELLI cells with ellipticine-induced cytoplasmic vacuolization and ellipticine is concentrated in these vacuoles. Confocal microscopy and staining of the cells with a lysosomal marker suggested these vacuoles as lysosomes. Transmission electron microscopy and no effect of an autophagy inhibitor wortmannin ruled out autophagy. Pretreatment with a V-ATPase inhibitor bafilomycin A and/or the lysosomotropic drug chloroquine prior to ellipticine enhanced the ellipticine‑mediated apoptosis and decreased ellipticine-resistance in UKF-NB-4ELLI cells. Moreover, pretreatment with these inhibitors increased formation of ellipticine-derived DNA adducts, one of the most important DNA-damaging mechanisms responsible for ellipticine cytotoxicity. In conclusion, resistance to ellipticine in the tested neuroblastoma cells is associated with V-ATPase-mediated vacuolar trapping of this drug, which may be decreased by bafilomycin A and/or chloroquine.Keywords
This publication has 44 references indexed in Scilit:
- ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cellsDiagnostic Pathology, 2012
- Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategyJournal of Experimental & Clinical Cancer Research, 2010
- Mechanisms of Amine Accumulation in, and Egress from, LysosomesBioanalysis, 2009
- Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cellsMolecular Cancer, 2009
- Inhibitors of V-ATPases: old and new playersJournal of Experimental Biology, 2009
- Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestrationLeukemia, 2008
- Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12‐hydroxyellipticine and 13‐hydroxyellipticineInternational Journal of Cancer, 2006
- Bafilomycin A1 Inhibits Chloroquine-Induced Death of Cerebellar Granule NeuronsMolecular Pharmacology, 2006
- Endocytic recyclingNature Reviews Molecular Cell Biology, 2004
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003